Correction: Corrigendum: Selective inhibition of EZH2 by ZLD1039 blocks H3K27methylation and leads to potent anti-tumor activity in breast cancer

Song, Xuejiao,Gao, Tiantao,Wang, Ningyu,Feng, Qiang,You, Xinyu,Ye, Tinghong,Lei, Qian,Zhu, Yongxia,Xiong, Menghua,Xia, Yong,Yang, Fangfang,Shi, Yaojie,Wei, Yuquan,Zhang, Lidan,Yu, Luoting
DOI: https://doi.org/10.1038/srep20864
IF: 4.6
2016-01-01
Scientific Reports
Abstract:Scientific Reports 6: Article number: 20864; Published online: 12 February 2016; Updated: 29 April 2016 This Article contains typographical errors. In the Results section under subheading ‘Impact of ZLD1039 on breast cancer cell growth’, “Among the cell lines, MCF-7 and ZR-75-1 were the most sensitive to ZLD1039 with IC50 values of 0.
What problem does this paper attempt to address?